Funding Opportunity Title: NIAID Clinical Trial Implementation Cooperative Agreement (U01)
Funding Organization: National Institutes of Health (NIH)
Total Funding Amount: Not limited, must reflect actual project needs
Duration: Maximum project period of 5 years
Primary Objective: Support high-risk clinical trials and mechanistic studies
Key Stakeholders: NIAID, investigators, and clinical trial participants
Funding Source: NIH
Grant Frequency: Recurring
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits (with and without 501(c)(3) status)
For-Profit Organizations
Small Businesses
Local, State, County, City Governments
Indian/Native American Tribal Governments (both recognized and non-recognized)
Federal Governments and Agencies
U.S. Territories or Possessions
Other entities including Independent School Districts, Public Housing Authorities, Faith-based Organizations, and Foreign Organizations
All applicants must have an eRA Commons account.
PD(s)/PI(s) must have the skills and resources necessary to carry out the proposed research.
High-risk clinical trials related to infectious, immunologic, and allergic diseases.
Mechanistic studies that promote understanding of human diseases.
Completion and analysis of the clinical trial.
Training of study personnel and management of trial activities.
Expertise in clinical trial design and implementation.
Knowledge of regulatory requirements for clinical trials.
Application budgets are not limited but must reflect actual project needs.
Open Date: April 12, 2024
Application Due Dates: Various deadlines through January 13, 2027
Compliance with federal regulations for clinical trials.
Adherence to NIH Grants Policy Statement.
Complete clinical protocol must be included in the application.
Resource Sharing Plan required for data management.